ARCHIVES

Herceptin Regimen Minus Adriamycin Increases Survival With Less Toxicity

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

Modeling Will Be Used For Other Populations

November 26, 2010

NCI Plans $30 Million In Patient-Oriented Chemoprevention research In Next 5 Years

December 6, 1996

Oncogens Variations May Exaplin Susceptibility, Familial Cancer, USC Investigators Report

September 23, 1988

Columbia Univ. Places cDNA Libraries In Public Domain

April 28, 1995

Antidepressant Provides Cool Choice For Hot Flashes

February 22, 2002

Four Detroit Institutions Merge Cancer Clinical, Research Programs

July 15, 1994